Amexdrug Corp. (AXRX) financial statements (2020 and earlier)

Company profile

Business Address 369 SOUTH DOHENY DR SUITE 326
BEVERLY HILLS, CA 90211
State of Incorp. CA
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments422
Cash and cash equivalents416
Short-term investments6
Receivables559
Inventory, net of allowances, customer advances and progress billings801
Inventory801
Prepaid expense and other current assets78
Other undisclosed current assets11
Total current assets:1,870
Noncurrent Assets
Property, plant and equipment489
Intangible assets, net (including goodwill)18
Goodwill18
Deposits noncurrent assets30
Other undisclosed noncurrent assets(488)
Total noncurrent assets:48
Other undisclosed assets22,489
TOTAL ASSETS:24,407
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities706
Accounts payable697
Accrued liabilities9
Debt756
Other undisclosed current liabilities180
Total current liabilities:1,642
Noncurrent Liabilities
Long-term debt and lease obligation336
Long-term debt, excluding current maturities336
Total noncurrent liabilities:336
Total liabilities:1,978
Stockholders' equity
Stockholders' equity attributable to parent430
Common stock169
Treasury stock, value(15)
Additional paid in capital(78)
Retained earnings353
Total stockholders' equity:430
TOTAL LIABILITIES AND EQUITY:2,407

Income statement (P&L) ($ in thousands)

12/31/2012
Revenues9,149
Cost of revenue(8,128)
Cost of goods and services sold(8,142)
Other undisclosed gross profit(14)
Gross profit:1,007
Operating expenses(791)
Other undisclosed operating loss(20)
Operating income:196
Nonoperating expense(36)
Other nonoperating expense(36)
Interest and debt expense38
Income from continuing operations before equity method investments, income taxes:198
Other undisclosed loss from continuing operations before income taxes(38)
Income from continuing operations before income taxes:160
Income tax expense(78)
Net income available to common stockholders, diluted:82

Comprehensive Income ($ in thousands)

12/31/2012
Net income:82
Comprehensive income, net of tax, attributable to parent:82

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: